Search results
Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers
The Independent via Yahoo News· 8 hours agoOzempic’s price “has decreased approximately 40 percent since launch and over 80 percent of...
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo News· 12 hours agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...
Joe Biden and Bernie Sanders Demand Drug Companies Cut Price of Ozempic and Other New Weight Loss...
Futurism via Yahoo News· 1 day agoIn a dual-bylined editorial, President Joe Biden and Sen. Bernie Sanders called on the makers of the...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News· 1 day ago“The overwhelming lesson from our dataset is that the earlier you identify a patient and give them...
Watchdog Calls on Eli Lilly to Denounce Supreme Court Puppetmaster’s Firm
Rolling Stone via Yahoo News· 1 day agoOn Wednesday, following the conclusion of another radically right-wing Supreme Court term, the...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo News· 1 day agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
5 things to know for July 3: Presidential race, Hurricane Beryl, India crowd crush, Alzheimer’s...
CNN via Yahoo News· 2 days agoAlzheimer’s treatment The FDA on Tuesday approved a new drug to slow the progression of early symptomatic Alzheimer’s disease. Donanemab, made by the pharmaceutical giant Eli
Fighting words: Lilly and Novo swat back at the Biden/Sanders call for lower GLP-1 prices
Yahoo Finance· 2 days agoNovo CEO Lars Jørgensen has agreed to testify before Sanders' committee in late September. But the...
FDA approves Lilly’s new Alzheimer’s drug after delay
The Hill via Yahoo News· 2 days agoThe Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company...
Best Performing ETFs by Sector in the Past 30 Days
Zacks via Yahoo News· 2 days agoMeanwhile, the big pharma companies are coming up with new drug data (read: Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?). India ETFs...